This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carbone, A. Articles by Dotti, G. Search for Related Content PubMed PubMed Citation Articles by Carbone, A. Articles by Dotti, G.

Lymphoma

EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

^aDepartment of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy; ^bCenter for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA

Key Words. EBV • EBV-associated lymphomas • Post-transplant–associated lymphoproliferative disorders • HIV-associated lymphoproliferative disorders • EBV cell–based immunotherapy

Correspondence: A. Carbone, M.D., Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, Milano I-20133, Italy. Telephone: 39-02-2390-2876; Fax: 39-02-2390-2877; e-mail: antonino.carbone{at}istitutotumori.mi.it

Received February 13, 2008; accepted for publication March 18, 2008.

Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or staff managers of this article.

Since its discovery as the first human tumor virus, Epstein-Barr virus (EBV) has been implicated in the development of a wide range of B-cell lymphoproliferative disorders, including Burkitt's lymphoma, classic Hodgkin's lymphoma, and lymphomas arising in immunocompromised individuals (post-transplant and HIV-associated lymphoproliferative disorders). T-cell lymphoproliferative disorders that have been reported to be EBV associated include a subset of peripheral T-cell lymphomas, angioimmunoblastic T-cell lymphoma, extranodal nasal type natural killer/T-cell lymphoma, and other rare histotypes. EBV encodes a series of products interacting with or exhibiting homology to a wide variety of antiapoptotic molecules, cytokines, and signal transducers, hence promoting EBV infection, immortalization, and transformation. However, the exact mechanism by which EBV promotes oncogenesis is an area of active debate. The focus of this review is on the pathology, diagnosis, classification, and pathogenesis of EBV-associated lymphomas. Recent advances in EBV cell–based immunotherapy, which is beginning to show promise in the treatment of EBV-related disorders, are discussed.

This article has been cited by other articles:

				O. Pozdnyakova, P. J. Spieler, J. Abraham, A. S. Freedman, and J. L. Kutok Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Immunocompetent Woman J. Clin. Oncol., February 10, 2010; 28(5): e75 - e78. [Full Text] [PDF]

				A. Sauter, C. Faul, M. Bitzer, R. Bares, S. Kraus, M. Fenchel, and M. Horger Imaging Findings in Immunosuppressed Patients With Epstein Barr Virus-Related B Cell Malignant Lymphoma Am. J. Roentgenol., February 1, 2010; 194(2): W141 - W149. [Abstract] [Full Text] [PDF]

				H Sokol and L Beaugerie Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle Gut, October 1, 2009; 58(10): 1427 - 1436. [Abstract] [Full Text] [PDF]

				A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz HIV-associated lymphomas and gamma-herpesviruses Blood, February 5, 2009; 113(6): 1213 - 1224. [Abstract] [Full Text] [PDF]